Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 1 minute read Healthcare Industry News FDA approves CeloNova Cobra PzF coronary stent system The US Food and Drug Administration (FDA) has approved the Cobra PzF nanocoated coronary stent system developed by… bypharmanewsdailyMarch 3, 2017
